Gene therapy cocktail shows promise in long-term clinical trial for rare fatal brain disorder

This form of gene therapy was created and developed at the UNC School of Medicine. The treatment uses a virus (adeno-associated virus, or AAV) as a “viral vector” meticulously tailored to enter the brain and safely switch good genes for bad.